Factors explaining the difference of total homocysteine between men and women in the European investigation into cancer and nutrition Potsdam study

被引:88
作者
Dierkes, J
Jeckel, A
Ambrosch, A
Westphal, S
Luley, C
Boeing, H
机构
[1] Univ Hosp Magdeburg, Inst Clin Chem & Biochem, Magdeburg, Germany
[2] German Inst Human Nutr, Dept Epidemiol, Potsdam, Germany
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 2001年 / 50卷 / 06期
关键词
D O I
10.1053/meta.2001.23286
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Interestingly, plasma total homocysteine (tHcy) concentration is consistently higher in men than in women. This observation deserves further investigations because elevated tHcy concentrations have been shown to be independently associated with coronary, peripheral, and cerebral vascular diseases. It was the aim of the present study to define major determinants of plasma tHcy in a healthy middle-aged German population under particular consideration of the gender factor. The study population was obtained from an ongoing recruitment procedure for a cohort study and comprised 336 men and women, aged 40 to 65 years. Exclusion criteria were elevated creatinine levels in blood, history of skin or atherosclerotic diseases, current use of vitamins or other supplements, and heavy smoking. Plasma tHcy, folate, vitamin B12, vitamin B6, creatinine. testosterone and estradiol, protein, and hematocrit were measured. Fat-free mass was assessed by skinfold thickness. The C677T polymorphism of the methylenetetrahydrofolate reductase (MTHFR). a key enzyme of folate and homocysteine metabolism, was determined by polymerase chain reaction (PCR) with restriction enzyme analysis. In this population, plasma tHcy ranged from 5 to 46 mu mol/L. The frequency of the T allele of the MTHFR was 0.29, which is lower than in other populations. A total of 54.2% of this population was homozygote for the wild-type, 39.6% heterozygote, and 6.2% homozygote for the mutation. tHcy correlated negatively with folate and cobalamin concentration in blood and positively with creatinine. No correlation was seen with vitamin B6. From the gender-related variables, tHcy correlated significantly with fat-free mass and testosterone and inversely with estradiol. The difference between gender with regard to tHcy was mainly explained by differences in fat-free mass, but also by estradiol concentrations. The following contributions to the variation of tHcy were seen in a multivariate regression model: plasma cobalamin (11%), creatinine (11%), plasma folate (8%), fat-free mass (5%), estradiol (2%), MTHFR polymorphisms (2%), and plasma protein (1%). We concluded that tHcy in the general population has a variety of determinants ranging from nutrition, internal metabolic parameters to gender-related variables. Copyright (C) 2001 by W.B. Saunders Company.
引用
收藏
页码:640 / 645
页数:6
相关论文
共 35 条
[1]  
ANDERSSON A, 1992, EUR J CLIN CHEM CLIN, V30, P377
[2]   The effect of reduced glomerular filtration rate on plasma total homocysteine concentration [J].
Arnadottir, M ;
Hultberg, B ;
NilssonEhle, P ;
Thysell, H .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1996, 56 (01) :41-46
[3]   DIFFERENCES BETWEEN PREMENOPAUSAL WOMEN AND YOUNG MEN IN THE TRANSAMINATION PATHWAY OF METHIONINE CATABOLISM, AND THE PROTECTION AGAINST VASCULAR-DISEASE [J].
BLOM, HJ ;
BOERS, GHJ ;
VANDENELZEN, JPAM ;
VANROESSEL, JJM ;
TRIJBELS, JMF ;
TANGERMAN, A .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1988, 18 (06) :633-638
[4]   Recruitment procedures of EPIC-Germany [J].
Boeing, H ;
Korfmann, A ;
Bergmann, MM .
ANNALS OF NUTRITION AND METABOLISM, 1999, 43 (04) :205-215
[5]   UNIQUE EFFICIENCY OF METHIONINE METABOLISM IN PREMENOPAUSAL WOMEN MAY PROTECT AGAINST VASCULAR-DISEASE IN THE REPRODUCTIVE YEARS [J].
BOERS, GH ;
SMALS, AG ;
TRIJBELS, FJ ;
LEERMAKERS, AI ;
KLOPPENBORG, PW .
JOURNAL OF CLINICAL INVESTIGATION, 1983, 72 (06) :1971-1976
[6]   Cystatin C as a determinant of fasting plasma total homocysteine levels in coronary artery disease patients with normal serum creatinine [J].
Bostom, AG ;
Bausserman, L ;
Jacques, PF ;
Liaugaudas, G ;
Selhub, J ;
Rosenberg, IH .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (09) :2241-2244
[7]   A QUANTITATIVE ASSESSMENT OF PLASMA HOMOCYSTEINE AS A RISK FACTOR FOR VASCULAR-DISEASE - PROBABLE BENEFITS OF INCREASING FOLIC-ACID INTAKES [J].
BOUSHEY, CJ ;
BERESFORD, SAA ;
OMENN, GS ;
MOTULSKY, AG .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (13) :1049-1057
[8]   HOMOCYSTEINE AND CYSTEINE - DETERMINANTS OF PLASMA-LEVELS IN MIDDLE-AGED AND ELDERLY SUBJECTS [J].
BRATTSTROM, L ;
LINDGREN, A ;
ISRAELSSON, B ;
ANDERSSON, A ;
HULTBERG, B .
JOURNAL OF INTERNAL MEDICINE, 1994, 236 (06) :633-641
[9]   Correlation of a common mutation in the methylenetetrahydrofolate reductase gene with plasma homocysteine in patients with premature coronary artery disease [J].
Christensen, B ;
Frosst, P ;
LussierCacan, S ;
Selhub, J ;
Goyette, P ;
Rosenblatt, DS ;
Genest, J ;
Rozen, R .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (03) :569-573
[10]   PREDICTION OF CREATININE CLEARANCE FROM SERUM CREATININE [J].
COCKCROFT, DW ;
GAULT, MH .
NEPHRON, 1976, 16 (01) :31-41